NABP is closely monitoring the effects of coronavirus (COVID-19) on our exams and scheduled surveys and inspections.
A list of emergency and temporary orders, policies, and board statements by state can be viewed here or on the boards of pharmacy page.
NABP Testing Program Customers
NAPLEX and MPJE Applicants
Pearson VUE is reopening its Pearson Professional Centers (PPCs) on May 1 or as local conditions allow. Candidates with valid ATTs may schedule exam appointments for May 1 and beyond. All rescheduling fees will be waived for those whose appointments were cancelled between March 16 and April 30.
Please be aware that there are currently fewer seats available due to social distancing guidelines, which require that testing sites operate at a smaller capacity than usual. NABP does not determine appointment priorities. Test site and appointment availability is determined by Pearson VUE based on local conditions.
If you are already licensed in at least one state, consider using the new NABP Passport, which facilitates non-resident temporary licenses as part of the COVID-19 pandemic response.
If your Authorization to Test (ATT) is still valid, you may use the same ATT. We are aware there will be capacity issues as site reopen and will work through these issues.
PCOA Administrators and Test Takers
We are working closely with schools and colleges of pharmacy who are scheduled to administer the PCOA over the coming months to accommodate school closures.
FPGEE ID Cards (FICs) will only be sent to candidates who have registered for the FPGEE and received an ATT. An email will be sent upon mailing of your FIC. Thank you for your patience as FICs are processed and mailed.
Educational Credential Evaluators (ECE) was closed from March 24 to April 21, 2020. They have resumed operations and are accepting applications again. Please see the ECE website for details.
FPGEC does not accept remote proctored exams or “My Best” scores. Check the ETS website for updates on test center availability.
If you have not yet submitted an FPGEC application, please do not apply until all of your documents are available for submission. This includes:
- Educational documents
- Pharmacy license/registration
- Passing TOEFL iBT score
Accreditation and Inspection Applicants
On March 19, 2020, NABP temporarily suspended all accreditation surveys and facility inspections due to the COVID-19 pandemic. As some states and geographic areas begin to ease restrictions and reopen, we are monitoring and applying current federal, state, and local guidelines and recommendations to determine if it is safe to again conduct surveys and inspections.
We will be assessing conditions in each state to determine if surveys and inspections can be conducted. We may be conducting surveys and inspections in the following states:
States Allowing Surveys and Inspections*
*DMEPOS surveys cannot take place.
Updated August 6
We will contact facilities in locations where a survey or inspection may occur. The list will be updated as additional states allow surveys and inspections to be conducted. Reference the list again at a later date if your state is not listed. We will work closely with applicants that have a pending survey or inspection and the assigned NABP staff or contractor to ensure all guidelines are met and followed up to and including the day of the inspection or survey. These must be met prior to an onsite survey or inspection being performed.
Contact the Accreditation and Inspection Programs department at 847/391-4539 with any questions or visit the Programs page for additional information.
There may be delays in NABP completing licensure transfer applications due to closures of some Boards of Pharmacy. We appreciate your patience as we work to complete applications as promptly as possible.
- How patients get infected and what to watch for from CDC
- Information on Coronavirus testing
- There are currently no treatments or cures. Patients should beware of and report products that claim to treat COVID-19
- Educational presentation from NABP
- NABP released the Rogue Rx Activity Report: Rogue Online Pharmacies in the Time of Pandemic: Capitalizing on Misinformation and Fear